Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

0.1425
-0.0172-10.77%
Volume:8.30M
Turnover:1.19M
Market Cap:69.68M
PE:-0.22
High:0.1567
Open:0.1527
Low:0.1402
Close:0.1597
52wk High:3.87
52wk Low:0.1138
Shares:489.00M
Float Shares:306.00M
Volume Ratio:1.92
T/O Rate:2.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6496
EPS(LYR):-0.7455
ROE:-783.37%
ROA:-62.39%
PB:-0.74
PE(LYR):-0.19

Loading ...

Gossamer Bio launches exchange offer, consent solicitation

TIPRANKS
·
May 18

Gossamer Bio Q1 net loss widens on higher R&D expenses

Reuters
·
May 18

Gossamer Bio launches exchange offer to cut over $120 million debt

Reuters
·
May 18

Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt With Existing Noteholder Support

THOMSON REUTERS
·
May 18

Gossamer Bio Q1 Operating Income USD -44.866 Million

THOMSON REUTERS
·
May 18

Gossamer Bio Q1 EPS USD -0.2

THOMSON REUTERS
·
May 18

Gossamer Bio Q1 EPS $(0.20) Misses $(0.13) Estimate, Sales $16.955M Beat $4.475M Estimate

Benzinga Earnings
·
May 18

U.S. Earnings Preview: Before Market Open May 18

Dow Jones
·
May 18

Gossamer Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

Top News Today: Stocks Slide, Treasury Yields Rise on Strait, Inflation Fears

Dow Jones
·
May 16

Gossamer Bio Q1 net loss widens to $46.66 million; revenue rises to $16.96 million

Reuters
·
May 16

Gossamer Bio to report first-quarter results, host conference call and webcast

Reuters
·
May 15

Press Release: Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026

Dow Jones
·
May 15

Gossamer Bio Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
May 11

Gossamer Bio announces annual shareholder meeting webcast

Reuters
·
Apr 25

Gossamer Bio Investors File Securities Lawsuit Over Alleged Misstatements About Phase 3 Drug Trial

TIPRANKS
·
Apr 23

Gossamer Bio gets Nasdaq notice for failing $1 minimum bid price rule

Reuters
·
Apr 10

Gossamer Bio Lawsuit: Investors Allege Misleading Statements Ahead of Failed PAH Trial

TIPRANKS
·
Apr 04

Analysts Conflicted on These Healthcare Names: Gossamer Bio (GOSS) and Biogen (BIIB)

TIPRANKS
·
Apr 02

Gossamer Bio Cut to Neutral From Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 23